The forecast for Business Enterprise R&D Expenditure in Scientific Research and Development in the US shows a steady increase from $48.9 billion in 2024 to $70.45 billion in 2028. This reflects a compound annual growth rate (CAGR) of approximately 9.4% over the five-year forecast period. Comparing the growth in 2025 and 2026, there is a notable year-on-year increase of 11% and 9.9% respectively. This consistent upward trend indicates robust investment in innovation and development.
Future trends to watch for include the impact of emerging technologies such as artificial intelligence and biotechnology, potential policy changes affecting R&D incentives, and shifts in global competitive dynamics that could influence investment priorities.
